References
- Chorzelski T. P., von Weiss J. F., Lever W. F. Clinical significance of autoantibodies in pemphigus. Arch Dermatol 1966; 93: 570–6
- Anhalt G. J., Kim S. C., Stanley J. R., Korman N. J., Jabs D. A., Kory M., et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729–35
- Vu T. N., Lee T. X., Ndoye A., Shultz L. D., Pittelkow M. R., Dahl M. V., et al. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol 1998; 134: 971–80
- Cotell X., Robinson N., Chan L. Autoimmune blistering skin diseases. Am J Emerg Med 2000; 18: 288–99
- Ruocco V., Ruocco E. Pemphigus and environmental factors. G Ital Dermatol Venereol 2003; 138: 299–309
- Kawana S., Hashimoto T., Nishikawa T., Nishiyama S. Changes in clinical features, histologic findings, and antigen profiles with development of pemphigus foliaceus from pemphigus vulgaris. Arch Dermatol 1994; 130: 1534–8
- Jarzabek‐Chorzelska M., Jablonska S., Kolacinska‐Strasz Z., Sulej I. Immunopathological diagnosis of pemphigus foliaceus. Dermatology 2002; 205: 413–15
- Hernandez C., Amagai M., Chan L. S. Pemphigus foliaceus: Preferential binding of IgG1 and C3 at the upper epidermis. Br J Dermatol 1997; 136: 249–52
- Schmidt E., Hunzelmann N., Zillikens D., Bröcker E. B., Goebeler M. Rituximab in refractory autoimmune bullous diseases. Clin Exp Dermatol 2006; 31: 503–8
- McLaughlin P., Grillo‐Lopez A. J., Link B. K., Levy R., Czuczman M. S., Williams M. E., et al. Rituximab chimeric anti‐CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four‐dose treatment program. J Clin Oncol 1998; 16: 2825–33
- Edwards J. C., Szczepanski L., Szechinski J., Filipowicz‐Sosnowska A., Emery P., Close D. R., et al. Efficacy of B cell‐targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004; 350: 2572–81
- Quartier P., Brethon B., Phillippet P., Landman‐Parker J., Le Deist F., Fischer A. Treatment of childhood autoimmune hemolytic anemia with rituximab. Lancet 2001; 358: 1511–13
- Torzecka J. D., Sysa‐Jedrzejowska A., Dziankowska‐Bartkowiak B., Waszczykowska E. Pemphigus foliaceus: An unusual clinical feature and case reports. Cutis 1998; 61: 21–4
- Arin M., Engert A., Krieg T., Hunzelmann N. Anti‐CD20 monoclonal antibody in the treatment of pemphigus. Br J Dermatol 2005; 51: 620–5